FDA, Janssen bolster cardiac risk warnings for cisapride.
Miller
J L
JL
D000897:Anti-Ulcer Agents / Q000009:adverse effects*; D001145:Arrhythmias, Cardiac / Q000139:chemically induced*; D020117:Cisapride / Q000009:adverse effects*; D004348:Drug Labeling; D006801:Humans; D014481:United States; D014486:United States Food and Drug Administration
D000897:Anti-Ulcer Agents; D020117:Cisapride